| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/05/2006 | EP1641758A2 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 04/05/2006 | EP1641757A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 04/05/2006 | EP1641756A1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor |
| 04/05/2006 | EP1641752A1 3- sulfonylamino- pyrrolidine- 2- one derivatives as inhibitors of factor xa |
| 04/05/2006 | EP1641535A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 04/05/2006 | EP1641423A2 Benzodiazepine cgrp receptor antagonists |
| 04/05/2006 | EP1305319B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/05/2006 | EP1300398B1 Propane-1,3-dione derivatives |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | EP1019372B1 Fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 04/05/2006 | CN1756754A Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 04/05/2006 | CN1756751A Process for production of sulfoxide derivatives or salts thereof in the amorphous state |
| 04/05/2006 | CN1756746A 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 04/05/2006 | CN1756551A New arylpiperazinyl compounds |
| 04/05/2006 | CN1756550A 2,5- and 2,6-substituted tetrahydroisoquinolines for use as 5-HT6 modulators |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1754879A Imidazole derivative compound, its salts and use thereof |
| 04/05/2006 | CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 04/05/2006 | CN1249056C Inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1249054C Process for preparation of aripiprazole |
| 04/05/2006 | CN1249053C Nitrate salt of anti-ulcer medicine |
| 04/05/2006 | CN1249052C Pyrazole derivatives as HIV reverse transcriptase inhibitors |
| 04/05/2006 | CN1249051C Muscarinic agonists |
| 04/05/2006 | CN1249036C Iron chelators and use thereof |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |
| 04/05/2006 | CN1248692C Use of corpus vitreum conjugated protein receptor antagon in preparation of medicine for inhibiting accretion generation |
| 04/05/2006 | CN1248683C Treatment of type 2 diabetes mellitus using inhibitors of dipeptidyl peptidase IV |
| 04/04/2006 | US7022859 crystallization in an ethanol or ethanol/water mixture after which ammonium hydroxide is added |
| 04/04/2006 | US7022858 Unsymmetrical methane and polymethine dyes having the formula: alpha-cyanomethine and alpha-cyanopolymethine dyes is provided having moieties which serve for the covalent attachment to biological substrates and resulting in the |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022736 Enzyme inhibitors |
| 04/04/2006 | US7022731 Cardiovascular disorders; thrombosis; anticoagulants |
| 04/04/2006 | US7022718 Pyridine and pyrimidine derivatives |
| 04/04/2006 | US7022717 Chemokine receptor binding heterocyclic compounds |
| 04/04/2006 | US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/04/2006 | US7022715 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/04/2006 | US7022714 e.g., 3-(2-piperidinylethyl)-2-(4-phenoxyphenyl)benzimidazole and 3-(2-piperidinylethyl)-2-(N-ethyl-3-carbazolyl)benzimidazole; functions as an antitinnitus agent, anticonvulsant, antiarrhythmic, local anesthetic, or antimanic depressant. |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022696 Treatment of airway disorders |
| 04/04/2006 | US7022695 Thioether-substituted benzamides as inhibitors of Factor Xa |
| 04/04/2006 | US7022690 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 04/04/2006 | US7022679 Processes for the preparation of 6-11 bicyclic erythromycin derivatives |
| 04/04/2006 | US7022650 Herbicides for broadleaf/gramineous weeds among crop plants |
| 04/04/2006 | US7022143 Dyeing composition for dyeing keratinous fibers comprising a cationic azo-dye |
| 04/04/2006 | CA2341031C Novel salt form of pantoprazole |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 04/04/2006 | CA2241787C Substituted aza- and diazacycloheptane and cyclooctane compounds and their use |
| 04/04/2006 | CA2235133C Esters of 3-hydroxy-piperidinemethanol derivatives |
| 04/04/2006 | CA2198266C Novel benzimidazole derivatives |
| 04/04/2006 | CA2193039C Indol-2-one derivatives |
| 04/04/2006 | CA2188507C Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same |
| 04/04/2006 | CA2166315C Process for the preparation of thalidomide |
| 04/04/2006 | CA2043976C Substituted phthalides and heterocyclic phthalides |
| 03/30/2006 | WO2006034474A2 Novel pyridine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | WO2006034473A2 Novel pyrimidine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | WO2006034338A1 Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
| 03/30/2006 | WO2006034235A2 Substituted quinoline and quinazoline inhibitors of quinone reductase 2 |
| 03/30/2006 | WO2006034116A1 Diaminotriazole compounds useful as protein kinase inhibitors |
| 03/30/2006 | WO2006034089A1 Azaspiroalkene and azaspiroalkane compounds with nicotinic cholinergic receptor activity |
| 03/30/2006 | WO2006033620A1 New heterocyclic amides |
| 03/30/2006 | WO2006033002A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| 03/30/2006 | WO2006033001A1 Quinoline compounds |
| 03/30/2006 | WO2006032994A2 Muscarinic receptor antagonists |
| 03/30/2006 | WO2006032631A1 Inhibitors of the interaction between mdm2 and p53 |
| 03/30/2006 | WO2006032541A1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 03/30/2006 | WO2006011024A3 New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 03/30/2006 | WO2006000912A3 Pyridyl piperazines for the treatment of cns disorders |
| 03/30/2006 | WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 03/30/2006 | WO2005117867A3 Monocyclic heterocycles as kinase inhibitors |
| 03/30/2006 | WO2005113536A3 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 03/30/2006 | WO2005097107A3 Diphenyl - indol-2-on compounds and their use in the treatment of cancer |
| 03/30/2006 | WO2005094251A3 M3muscarinic acetylcholine receptor antagonists |
| 03/30/2006 | WO2005047899A3 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| 03/30/2006 | US20060069257 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants |
| 03/30/2006 | US20060069256 Ophthalmic compositions for treating ocular hypertension |
| 03/30/2006 | US20060069147 hydrolase enzyme antagonists such as N-{(6S,9R,11R)-2-[5-4-fluoroophenyl)-1-methyl-1H-pyrazol-3-yl]-5,6,7,8,9,10-hexahydro-6,9-methanobenzo[a][8]annulen-11-yl}-N'-(2,2,2-trifiuoroethyl)sulfamide that inhibit processing of amyloid precursor protein, useful in treating or preventing Alzheimer's disease |
| 03/30/2006 | US20060069130 Novel crystals |
| 03/30/2006 | US20060069129 Chemokine receptor binding heterocyclic compounds |
| 03/30/2006 | US20060069128 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 03/30/2006 | US20060069126 Pharmaceutically active isoindoline derivatives |
| 03/30/2006 | US20060069120 Novel piperidine derivaties as modulators of chemokine receptor ccr5 |
| 03/30/2006 | US20060069112 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/30/2006 | US20060069109 Therapeutic agents |
| 03/30/2006 | US20060069106 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide |
| 03/30/2006 | US20060069105 Protein tyrosine kinase inhibitors |
| 03/30/2006 | US20060069103 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 03/30/2006 | US20060069102 such as 2-Morpholin-4-yl-thiazole-4-carboxylic acid (5,6-dimethyl-1H-benzoimidazol-2-yl)-amide, used for the treatment of dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's, Alzheimer's, Parkinson's, Meniere's and Creutzfeld-Jacob Disease |
| 03/30/2006 | US20060069090 Triazine compounds |
| 03/30/2006 | US20060069088 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 03/30/2006 | US20060069084 Methods of inhibiting kinases |
| 03/30/2006 | US20060069077 Receptor-type kinase modulators and methods of use |
| 03/30/2006 | US20060069034 Antipathogenic benzamide compounds |
| 03/30/2006 | CA2582512A1 Compounds, compositions containing them, preparations thereof and uses thereof ii |
| 03/30/2006 | CA2581623A1 Novel pyridine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | CA2581492A1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 03/30/2006 | CA2581462A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| 03/30/2006 | CA2580844A1 Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
| 03/30/2006 | CA2580762A1 Heterocyclic derivatives and their use as therapeutic agents |
| 03/30/2006 | CA2580610A1 Diaminotriazole compounds useful as protein kinase inhibitors |